Literature DB >> 7797358

Longitudinal development of lipoprotein levels in males and females aged 12-28 years: the Amsterdam Growth and Health Study.

J W Twisk1, H C Kemper, G J Mellenbergh.   

Abstract

BACKGROUND: In the Amsterdam Growth and Health Study, the longitudinal development of risk factors for coronary heart disease (CHD) was investigated.
METHODS: Serum cholesterol (TC), high density lipoprotein (HDL) and the TC/HDL ratio were measured at the ages of 13, 14, 15 and 16 years (adolescence) and at the ages of 21 and 27 years ([young] adulthood).
RESULTS: No cohort, time of measurement, drop-out or test/learning effects were found for TC, HDL and the TC/HDL ratio. For males the longitudinal development of TC showed a dip in the adolescent period, while females showed constant values. For both males and females TC values increased during young adulthood, but females had higher (P < or = 0.001) absolute values than males. The HDL values for males decreased throughout the measurement period, while for females a stable period during adolescence was followed by a slight increase during adulthood. For the TC/HDL ratio males showed an increase during young adulthood, while females stayed more or less constant over the whole measurement period. The percentages of subjects above (or below for HDL) objective risk values increased with age: from 0% to 1% during adolescence to 11% (males) and 14% (females) for TC, 5% (males) and 1% (females) for HDL and 13% (males) and 1% (females) for the TC/HDL ratio.
CONCLUSIONS: In a relatively young and healthy population TC and TC/HDL values tended to rise with age (especially in males) indicating that prevention related to these risk factors for CHD should start early in life.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797358     DOI: 10.1093/ije/24.1.69

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  7 in total

1.  The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins.

Authors:  H Snieder; L J van Doornen; D I Boomsma
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Relation between the longitudinal development of lipoprotein levels and biological parameters during adolescence and young adulthood in Amsterdam, The Netherlands.

Authors:  J W Twisk; H C Kemper; G J Mellenbergh; W van Mechelen
Journal:  J Epidemiol Community Health       Date:  1996-10       Impact factor: 3.710

3.  A new approach to tracking of subjects at risk for hypercholesteremia over a period of 15 years: The Amsterdam Growth and Health Study.

Authors:  J W Twisk; H C Kemper; G J Mellenbergh; W van Mechelen
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

4.  Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes.

Authors:  M Loredana Marcovecchio; R Neil Dalton; A Toby Prevost; Carlo L Acerini; Timothy G Barrett; Jason D Cooper; Julie Edge; Andrew Neil; Julian Shield; Barry Widmer; John A Todd; David B Dunger
Journal:  Diabetes Care       Date:  2009-01-26       Impact factor: 17.152

5.  Changes in Fasting Lipids during Puberty.

Authors:  Mona A Eissa; Nicole L Mihalopoulos; Richard Holubkov; Shifan Dai; Darwin R Labarthe
Journal:  J Pediatr       Date:  2015-12-22       Impact factor: 4.406

6.  Nutrient intake, physical activity, and CVD risk factors in children: Project HeartBeat!

Authors:  R Sue Day; Janet E Fulton; Shifan Dai; Nicole L Mihalopoulos; Danielle T Barradas
Journal:  Am J Prev Med       Date:  2009-07       Impact factor: 5.043

7.  Age, maturation and serum lipid parameters: findings from the German Health Survey for Children and Adolescents.

Authors:  Anja Schienkiewitz; Julia Truthmann; Andrea Ernert; Susanna Wiegand; Karl Otfried Schwab; Christa Scheidt-Nave
Journal:  BMC Public Health       Date:  2019-12-03       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.